Progression of skin autofluorescence of AGEs over 4 years in patients with type 1 diabetes.
Kalina RajaobelinaCatherine HelmerFritz-Line Vélayoudom-CéphiseSovanndany NovBlandine FargesEmilie PupierLaurence BlancoMarie HugoHenri GinRigalleau VincentPublished in: Diabetes/metabolism research and reviews (2017)
The skin autofluorescence of advanced glycation end-products progresses in patients with type 1 diabetes, more if they have diabetic nephropathy, less if they are treated by continuous subcutaneous insulin infusion. This progression is associated with the development of nephropathy.